Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.

A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...

SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III ...

The Food and Drug Administration (FDA) has granted Fast Track designation to ANX005 (Annexon Biosciences) for the treatment of Guillain-Barré Syndrome (GBS), an autoimmune disease that can lead ...

Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long ...

Annexon is making significant strides with ANX005, which has shown encouraging results from Phase 3 trials for Guillain-Barré syndrome, an acute neuromuscular disease with no FDA-approved treatments.

Patients with Guillain- Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness.

Guillain-Barré syndrome (GBS) is rare, but most cases follow an infection with a virus or bacteria. GBS affects the nerves that control muscle movement and impacts immune system.

KYOTO, Japan — Eculizumab (Soliris, Alexion Pharmaceuticals) is safe for the treatment of patients with severe Guillain-Barré syndrome (GBS), a new phase 2 study shows.However, although more ...

It's been eight years since Rob Vasquez was diagnosed with Guillain-Barré Syndrome. 24/7 Live Fresno County North Valley South Valley Foothills/Sierra. ... These are symptoms of the condition.

Patients whose IgG levels increase less after treatment of GBS with IVIg have worse outcomes ... Intravenous Immunoglobulin IgG Response Associated with Poor Outcome in Guillain-Barré Syndrome.

Sufjan Stevens gave a rare health update following his 2023 diagnosis with Guillain-Barré syndrome "I’m okay. Situation normal, all up, kind of a thing," Stevens said in an interview with Vulture ...